Scott Schachter, OD, features a guest in his latest blog: Peter Pham, MD, founder and CEO of Zocular. Dr. Pham shares how a need to find a treatment for his own dry eyes prompted him to launch Zocular, their best-selling products and the effect on treating demodex, as well as what's next in the eyecare pipeline for the company.
Dr. Schachter has no financial interest in Zocular.
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or MultiMedia Healthcare LLC.
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.